CAPS Rating

CheapHessian (< 20)

Results 1 - 20 of 45 : 1 2 3 Next »
Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
17/03/2014 FNV.US 4 out of 5 Outperform 5Y $51.59 $49.59 (-1.04%) -3.88% +10.60% -14.48
17/03/2014 TGD.US 2 out of 5 Outperform 5Y $1.70 $0.75 (-0.95%) -55.72% +10.60% -66.32
17/03/2014 GDXJ.US 3 out of 5 Outperform 5Y $44.00 $23.97 (-2.28%) -45.52% +10.60% -56.13
17/03/2014 LODE.US 1 out of 5 Outperform 5Y $1.94 $0.64 (-2.15%) -67.22% +10.60% -77.82
17/03/2014 AEM.US 3 out of 5 Outperform 5Y $33.93 $29.14 (-3.22%) -14.13% +10.60% -24.73
17/03/2014 ANVGQ.US 2 out of 5 Outperform 5Y $6.37 $0.12 (+1.74%) -98.16% +10.60% -108.77
17/03/2014 GG.US 3 out of 5 Outperform 5Y $27.78 $18.60 (-1.95%) -33.05% +10.60% -43.66
29/02/2012 16/03/2014 AMZN.US 3 out of 5 Underperform 3Y $179.70 $367.35 (-0.97%) +104.42% +49.46% -54.96
26/02/2013 EXK.US 3 out of 5 Outperform 5Y $6.21 $2.07 (-3.72%) -66.67% +37.10% -103.77
11/02/2013 FSM.US 2 out of 5 Outperform 5Y $4.47 $3.88 (-2.27%) -13.20% +35.28% -48.48
11/02/2013 PAAS.US 3 out of 5 Outperform 5Y $15.93 $9.19 (-2.85%) -42.31% +35.28% -77.58
05/02/2013 RIC.US 2 out of 5 Outperform 5Y $3.20 $3.20 (+1.91%) 0% +36.53% -36.53
05/02/2013 AXU.US 4 out of 5 Outperform 5Y $4.58 $0.36 (-4.74%) -92.10% +36.53% -128.62
04/02/2013 SSRI.US 5 out of 5 Outperform 5Y $12.09 $5.03 (-2.61%) -58.35% +36.56% -94.91
04/02/2013 GORO.US 2 out of 5 Outperform 5Y $12.42 $3.24 (-0.92%) -73.92% +36.56% -110.47
24/01/2013 SGSVF.US 2 out of 5 Outperform 5Y $2.51 $0.30 (+6.07%) -88.24% +37.63% -125.86
23/01/2013 NRT.US 5 out of 5 Outperform 1Y $20.75 $12.12 (+0.33%) -41.60% +37.65% -79.25
23/01/2013 POT.US 4 out of 5 Outperform 5Y $38.52 $32.82 (+0.67%) -14.80% +37.65% -52.44
23/01/2013 CPE.US 2 out of 5 Outperform 5Y $5.22 $7.93 (+3.52%) +51.92% +37.65% +14.27
14/01/2013 IAG.US 3 out of 5 Outperform 5Y $10.58 $2.06 (-1.44%) -80.53% +39.74% -120.28
Results 1 - 20 of 45 : : 1 2 3 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.